Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dermatophagoides pteronyssinus is a house dust mite whose allergens are a major cause of allergic diseases. The primary allergens, Der p 1, Der p 2, and Der p 23, trigger IgE-mediated hypersensitivity reactions and can also activate innate immune pathways. Exposure to these allergens leads to symptoms like rhinitis, asthma, and eczema. Diagnosis involves skin-prick testing or measuring specific IgE levels. Treatment includes allergen avoidance, medications, and allergen immunotherapy.
IgE crosslinking on mast cells and basophils, leading to histamine and mediator release; TLR4 activation (Der p 2)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dermatophagoides pteronyssinus allergen.